Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3463436 Title: UN VACCIN EN COMBINAISON AVEC UN INHIBITEUR DE POINT DE CONTRÔLE IMMUNITAIRE POUR LE TRAITEMENT DE CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
177290780
WO application number:
EP2017063589
Type:
European patent granted for BE
Status:
Open
Publication number:
3463436
WO publication number:
WO2017207814
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
02/06/2017
Grant date:
20/09/2023
EP publication date:
10/04/2019
WO publication date:
07/12/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
20/09/2023
EP B1 publication date:
20/09/2023
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
02/06/2037

Applicant

Name:
Ultimovacs ASA
Legal Form:
From:
20/09/2023
Address:
Ullernchausséen 64, 0379 Oslo, Norway (NO)
To:

Agent

Name:
POLVERARI Luca
Legal Form:
From:
29/11/2023
Address:
44, rue de la Vallée B.P. 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
GAUDERNACK, Gustav
Legal Form:
Address:
1337 Sandvika, Norway (NO)

2

Name:
TORNES, Audun
Legal Form:
Address:
3021 Drammen, Norway (NO)

Priority

Priority patent number:
16172760
Priority date:
02/06/2016
Priority country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
A61K 39/00; C07K 16/28;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2023/18
Publication date:
09/10/2023
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202338
Publication date:
20/09/2023
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
30/06/2025
Annual fee number:
9
Annual fee amount:
165 Euro
Expected payer:
Last annual fee payment date:
22/04/2024
Last annual fee paid number:
8
Last annual fee paid amount:
135 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
29/11/2023 Outgoing Correspondence 1 PDF /7/2/3/1/5/0722351327/docs/177290780_0_outgoingcorrespondence_20231130_084607935.pdf
29/11/2023 Incoming Correspondence (Email) Cover letter 1 PDF /7/2/3/1/5/0722351327/docs/177290780_1_incomingcorrespondenceelectronic_20231130_084608253.pdf
29/11/2023 General Document Declaration of domicile 1 PDF /7/2/3/1/5/0722351327/docs/177290780_2_generaldocument_20231130_084608087.pdf